Skip to main content
Frontiers in Psychiatry logoLink to Frontiers in Psychiatry
. 2026 Aug 5;17:1925564. doi: 10.3389/fpsyt.2026.1925564

Integration of specialized residential interventions with community-based services for autistic adults with severe challenging behaviors: preliminary evidence from the Piedmont model

Roberto Keller 1, Martina Giacchero 1, Francesca Capiotto 1, Martina Masoero 1, Stefano Corna 2, Giusi Figliano 2, Marilia Barbosa De Matos 2, Donato Liloia 1,3,*
PMCID: PMC13487500  PMID: 42620924

Abstract

Background

Severe challenging behaviors in autistic adults are difficult to manage in generic psychiatric settings and impose a heavy burden on individuals, families, and services. The Piedmont Region (Italy) established a specialized third-level inpatient unit for these presentations, embedded within an integrated, three-tier regional network. This study reports preliminary effectiveness data from this model.

Materials and methods

In a prospective, pre-post design, 10 autistic adult males admitted for severe challenging behaviors received an intensive, individualized psychoeducational program based on Applied Behavior Analysis during a time-limited specialized admission. Psychopathology (Brief Psychiatric Rating Scale, BPRS), challenging behaviors (Aberrant Behavior Checklist, ABC), global clinical severity (Clinical Global Impression, CGI), and social support (Social and Affective Functional Support Scale, SSAF) were assessed before admission (T0) and at discharge (T1). Change was examined with paired-samples t-tests and standardized effect sizes; given the sample size and number of comparisons, analyses were exploratory.

Results

Improvement was selective rather than uniform. On the BPRS, significant reductions emerged across several dimensions, concentrated in a coherent behavioral-disorganization and agitation cluster (i.e., motor tension, distractibility, bizarre behavior, conceptual disorganization, and anxiety) with large effect sizes. The ABC showed significant reductions in lethargy/social withdrawal and hyperactivity, whereas stereotypic behavior, irritability, and inappropriate speech did not change significantly. CGI and SSAF showed non-significant trends toward improvement. Trait-like, affective, and global dimensions appeared least responsive to the admission.

Conclusion

A time-limited, specialized inpatient program delivered within an integrated regional network was associated with improvement concentrated in observable, modifiable behavioral dimensions. These preliminary findings support the development of specialized, coordinated care pathways for severe challenging behaviors in autistic adults and warrant controlled studies with larger, sex-diverse samples and post-discharge follow-up.

Keywords: adulthood, applied behavior analysis, autism spectrum disorder, challenging behaviors, inpatient care, specialized care pathway

Introduction

Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition defined by persistent differences in social communication and reciprocal interaction, restricted and repetitive patterns of behavior and interests, and atypical sensory processing (1). Because these features vary widely in expression and intensity, the clinical needs of autistic people differ markedly across individuals and across the lifespan (2–6). For a subset of autistic people, most often those with co-occurring intellectual disability and limited spoken language, adolescence and adulthood bring behaviors that are severe, persistent, and difficult to contain: aggression, self-injury, and prolonged agitation, commonly grouped under the term challenging behaviors (7–9). These are among the most consequential problems in adult autism care. They erode the autistic person’s participation and autonomy, shape the quality of life of entire families and, when they escalate, precipitate emergency presentations, psychiatric admission, and the use of coercive measures (10). Their assessment and management are correspondingly demanding, and the stakes are high for the individual, the family, and the service system (8, 11).

Current guidance, including that of the Italian National Institute of Health (Istituto Superiore di Sanità 2025), converges on the view that no single intervention is appropriate for all autistic presentations; rather, care should be personalized, intensive, and delivered by a multidisciplinary team (12). Therefore, addressing severe challenging behavior requires a structured, sequential process. Organic and medical contributors must first be excluded, an especially important step in non-speaking individuals, in whom somatic pain, gastrointestinal disturbance, or epilepsy may underlie an apparent behavioral crisis (13). Environmental and contextual triggers, such as sensory load or disruption of routine, must then be identified. Beyond these precipitants, chronic challenging behaviors are frequently learned responses maintained by their consequences: they serve a function for the individual while simultaneously interfering with adaptive functioning, social participation, and overall quality of life (8, 14, 15). Functional behavior assessment seeks to identify the antecedents and consequences that maintain a behavior, providing the empirical basis for individualized intervention (16–18).

Applied Behavior Analysis (ABA) operationalizes these principles through the systematic use of reinforcement, extinction, shaping, and related procedures to increase adaptive behavior and reduce behavior that is harmful or maladaptive (19, 20). Meta-analytic evidence supports the efficacy of intensive ABA intervention for communication, adaptive, and cognitive skills in autistic children, particularly when delivered early and at high intensity (21–25). However, the evidence base for adults is considerably weaker. A systematic review identified only a small number of eligible studies, most of which used single-case or non-randomized designs; the reported effects were promising but heterogeneous and supported by low-certainty evidence (26). The extension of behavioral approaches to autistic adults also warrants caution on conceptual and ethical grounds, given ongoing debate about the social validity of behavior-reduction goals and the priority that autistic people and their families place on well-being, autonomy, and the least restrictive effective intervention (27–30). Taken together, these considerations argue for delivering behavioral intervention within a comprehensive, medically informed, and person-centered framework rather than as an isolated technique, and they underscore the need for empirical evaluation of such integrated models in the adult population.

The setting in which intensive intervention is delivered is itself consequential. General psychiatric inpatient wards may expose autistic people in crisis to high sensory and social load, including noise, bright lighting, alarms, crowding, disrupted routines, and unpredictability; these conditions conflict with autism-informed principles that emphasize structure, predictability, low arousal, individual sensory adaptations, and co-regulation, and may contribute to dysregulation, overwhelm, and escalation of the behaviors that admission is intended to contain (31, 32). Accumulating evidence indicates that specialized inpatient environments yield better outcomes than general units for this population (33). Resistant behavioral crises associated with autism and intellectual disability can stabilize within dedicated, interdisciplinary neurobehavioral units (13, 34, 35). Nonetheless, such services remain scarce, are concentrated in childhood and adolescence, and are seldom embedded within the wider system of community care; the limited capacity of autism-specialized inpatient provision for adults is a recognized gap internationally (36). Importantly, few published and outcome-evaluated models have described specialized residential or supported-living interventions for autistic adults with severe challenging behaviors that are explicitly embedded within wider community health and social-care pathways (37–41). This gap appears particularly pronounced in Italy, where adult autism services and residential initiatives exist. However, the available evidence remains largely service-descriptive rather than grounded in systematically evaluated, adult-specific residential models (42, 43).

The Piedmont Region in north-western Italy has recently developed such a model. Its care system is organized in a structured network across three levels: first-level autism outpatient clinics and community mental health centers located within each local health authority (Azienda Sanitaria Locale, ASL); two regional second-level autism centers, one for children and one for adults, providing specialist multidisciplinary consultation to local services (12, 44); and, most recently, a dedicated third-level inpatient facility for autistic individuals with severe challenging behaviors, structurally independent of standard acute psychiatric wards. Located at IRCCS Maugeri, this unit provides diagnostic assessment, ABA-based functional analysis, medical and pharmacological re-evaluation, and stabilization of complex presentations through an intensive multi-month protocol grounded in national guidelines (Istituto Superiore di Sanità 2025; Società Italiana di Neuropsichiatria dell’Infanzia e dell’Adolescenza 2005). Crucially, the unit is not conceived as a site for acute crisis containment alone; it operates in continuous coordination with the referring territorial teams before admission and with structured post-discharge projects afterwards, forming an integrated “Piedmont model” of care. This configuration anticipates the model that the Istituto Superiore di Sanità is now promoting nationally through EDECO (Equipe Dedicate alle Emergenze Comportamentali; Dedicated Teams for Behavioral Emergencies), a program that structures the response to challenging behavior in ASD across three levels of increasing specialization and complexity. First-level teams, widely distributed across the territory, provide first-line assessment and intervention for outpatients with ASD and behavioral difficulties; second-level teams—comprising psychiatrists and psychologists trained in cognitive-behavioral treatments specific to challenging behavior in ASD—deliver more specialized intervention and support the first-level teams; and third-level teams provide inpatient care for individuals with severe challenging behavior who require admission to a ward dedicated to ASD and kept distinct from general psychiatric settings. The Piedmont system described above can thus be regarded as an early, fully operational instance of this three-tier logic.

Against this background, the present study reports preliminary, real-world data on the intensive protocol delivered at IRCCS Maugeri, using a within-subject pre-post design. Standardized instruments were administered before admission and after discharge by the referring ASL services to capture several domains, including challenging behaviors and their functional characteristics, psychiatric symptom severity, global clinical status, and clinical change. Given its naturalistic design and small sample size, the present study should be regarded as an exploratory evaluation of the preliminary effectiveness of the integrated inpatient treatment model, rather than as a confirmatory trial. Consistent with the rationale for individualized, ABA-informed intervention embedded within comprehensive medical care, we anticipated reductions in challenging behaviors and in associated psychopathological symptoms, while expecting that broader, more structural indices of autism severity and support need would be less likely to change over the course of a relatively short admission.

Materials and methods

Structured intervention and unit

The third-level service at Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Maugeri (https://icsmaugeri.it/) is organized as a specialized unit dedicated to managing severe, challenging behaviors in adolescents (aged 14–18 years) and adults diagnosed with ASD, operating through an integrated psychoeducational and clinical approach. The multidisciplinary team includes psychiatrists, child neurologists, psychologists, behavior analysts, professional educators, nurses, and healthcare support staff, ensuring integrated, comprehensive, and coordinated care. Referral and subsequent admission to IRCCS Maugeri are determined by the regional autism units for children or adults within the territorial ASL. Inpatient admission is considered the most appropriate therapeutic setting for individuals whose challenging behaviors require intensive management within a structured and highly specialized environment. Referrals are therefore made by the ASL services to Maugeri, which, following an initial meeting with the patient and family, admits the individual to the unit and develops an individualized intervention plan. Within this three-tier network, referrals to the third-level unit are made by the second-level regional autism centers, which coordinate and, where required, escalate cases identified by the first-level outpatient and community services.

To optimize the planning of the intensive intervention, a standardized admission and assessment protocol was developed. The process, summarized below in its main phases, includes:

  • Receipt of the admission request from the referring autism centers and neuropsychiatric services;

  • Initial contact with the referring clinicians for a preliminary description of the case;

  • Interviews with family members, caregivers, and/or professionals already involved in the patient’s care, together with the administration of a pre-admission information questionnaire aimed at collecting data on adaptive functioning, educational profile, academic abilities, and characteristics of the challenging behaviors;

  • Preliminary visit to the unit by family members and, whenever possible, by the patient, during which information regarding the stay and therapeutic program is provided;

  • Admission to the unit with reception by the case manager (psychologist), the reference educator, and the nursing coordinator, including support for environmental adaptation and logistical organization;

  • During the first week, completion of routine clinical examinations (performed by the unit’s medical staff, i.e., psychiatrists and, where indicated, other on-site specialists) and initiation of systematic observations (initiated by the reference educators and nursing staff, in coordination with the behavior analyst) concerning autonomy, existing abilities, and behavioral criticalities;

  • After the first week, implementation of structured observation sessions with the behavior analyst and the reference educator;

  • Development of the first educational and behavioral recommendations, together with the definition of data collection procedures;

  • Every 15 days, multidisciplinary micro-team meetings aimed at reviewing collected data, evaluating intervention effectiveness, and redefining clinical and educational goals;

  • Ongoing collaboration with an external supervising psychologist;

  • Continuous coordination with the territorial services responsible for the patient’s care, to share treatment progress and therapeutic goals.

The psychoeducational approach adopted by the unit is based on the principles of ABA, integrated within an intensive and individualized model aimed at reducing dysfunctional behaviors and enhancing adaptive skills. Within the inpatient setting, this approach is intended to provide an intensive intervention delivered within the expected duration of stay, while also preparing the patient for discharge and future placement in residential and/or home settings. The main phases are described in Table 1.

Table 1.

Summary of the unit’s operational procedure.

Phase Main activities Included assessments
Admission referral Referral from adult or child autism centers or child neuropsychiatry services –
Initial consultation with referring clinicians Collection of preliminary clinical information –
Family/caregiver interview Clinical interview and pre-admission questionnaire Preliminary observational assessment
Preliminary visit to the unit Information regarding inpatient stay and treatment program –
Admission to the unit Initial assessment and environmental adaptation –
First week of admission Clinical examinations and systematic observations Cognitive assessment and observational scales
Structured observation sessions Behavioral observations conducted by the behavior analyst Functional behavioral assessment
Development of behavioral and educational recommendations Definition of data collection procedures Observational data analysis
Multidisciplinary team meetings Data review and revision of clinical goals Adaptive and behavioral monitoring
Coordination with community services Sharing treatment progress and care planning –
Pre-discharge assessment Preparation for post-discharge transition Reassessment of adaptive functioning and cognitive profile

Psychoeducational intervention

The psychoeducational intervention adopted by the unit was based on the principles of ABA (19, 20), which includes:

  • Functional behavior assessment aimed at identifying antecedent and consequent variables maintaining a behavior (18);

  • Breakdown of complex skills into smaller and teachable units through task analysis and prompting procedures;

  • Systematic use of reinforcement to increase the frequency of desired behaviors, in accordance with the principles of operant conditioning;

  • Procedures aimed at reducing challenging behaviors through differential interventions, extinction, or manipulation of environmental contingencies;

  • Continuous data monitoring, including graphical evaluations and trend analyses to guide clinical decision-making (20);

  • Individualization of the intervention program, adapted to the characteristics of the individual and modified according to observed progress.

The methodological approach adopted by the unit is aligned with the guidelines of Società Italiana di Neuropsichiatria dell’Infanzia e dell’Adolescenza (2005) and the Guidelines of the Italian National Institute of Health (Istituto Superiore di Sanità, 2025), which identify behavioral interventions as the treatment of choice for autism, highlighting in particular the evidence supporting ABA in improving intellectual functioning, language abilities, and adaptive behaviors.

Outcome measures and diagnostic characterization

Admission and discharge assessments were conducted by the Adult Autism Outpatient Clinic of the ASL Città di Torino, the regional coordinating center, before admission (T0) and at discharge (T1). The T0 and T1 outcome assessments were completed with the support of a healthcare professional or caregiver who had extensive knowledge of the participant’s daily functioning, thereby providing collateral information on the participant’s clinical and functional status at the time of assessment. All participants were already receiving care from the Adult Autism Outpatient Clinic of the ASL Città di Torino and had previously undergone the standard diagnostic pathway adopted by the service (12). The core diagnostic pathway included cognitive assessment using the Wechsler Adult Intelligence Scale–Fourth Edition (WAIS-IV) (45), autism-specific diagnostic assessment using the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) (46), and the Autism Diagnostic Interview–Revised (ADI-R) (47). When clinically indicated, additional structured assessments were administered to support differential diagnosis and characterize co-occurring conditions. In participants presenting with symptoms of inattention or hyperactivity, the Diagnostic Interview for ADHD in Adults, Fifth Edition (DIVA-5) (48), was used to assess ADHD symptoms during both childhood and adulthood, with collateral information from a caregiver when available. The Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5) (49) was also administered when further assessment of personality functioning was required to distinguish autism-related features from symptoms attributable to a co-occurring personality disorder. The outcome measures were completed by trained clinicians from the multidisciplinary team of the Adult Autism Outpatient Clinic.

When challenging behaviors escalated to a level requiring admission to the tertiary-level service, participants underwent the T0 assessment protocol described below. Co-occurring psychiatric and medical conditions were recorded by the clinician responsible for completing the admission protocol, based on diagnoses and other information documented in the available clinical records.

The outcome battery comprised:

  • Brief Psychiatric Rating Scale (BPRS) (50): assessing the severity of 24 different psychiatric symptoms using a 7-point Likert scale.

  • Aberrant Behavior Checklist (ABC) (51): a 58-item informant-rated scale comprising five subscales, namely irritability, lethargy/social withdrawal, stereotypic behavior, hyperactivity/noncompliance, and inappropriate speech.

  • Clinical Global Impression (CGI) (52): evaluating global functioning through a 7-point severity scale. It also includes a 7-point score assessing change following treatment, ranging from worsening of the clinical condition to marked improvement.

  • Social and Affective Functional Support Scale (SSAF) (53): collecting information regarding challenging behaviors, including their intensity and frequency, social influences on behavior, and reinforcement variables.

Data analysis

Statistical analyses were conducted to evaluate the impact of the intervention by comparing baseline (T0) and discharge (T1) assessments. Given the within-subject design, differences between the two assessment time points were analyzed using two-tailed paired-samples t-tests. Analyses were conducted separately for each subscale of the instruments used for patient assessment. Descriptive statistics were calculated using all valid observations available at each assessment time point, whereas each paired-samples t-test included only participants with valid scores at both T0 and T1 for the corresponding outcome. All statistical analyses were performed using IBM SPSS Statistics 30 (https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-30). The significance threshold was set at α = .05; t values, degrees of freedom (df), significance levels, and effect sizes (Cohen’s dz) were reported, and results outside the α = .05 threshold were interpreted descriptively with reference to their effect sizes, rather than being described as statistical trends. Given the number of subscale comparisons performed relative to the sample size, no correction for multiple comparisons was applied, and the analyses are therefore explicitly exploratory rather than confirmatory.

Results

The study sample consisted of the first 10 patients with ASD who were consecutively admitted following implementation of the program and who completed it. All participants were adult males, aged 20.2-43.0 years (M = 27.8 years, SD = 9.5). No sex-based eligibility criterion was applied; the exclusively male composition reflected the sex distribution of patients referred to and admitted to the service during the study period. Clinical and sociodemographic characteristics, together with the duration of hospitalization and comorbidities, are reported in Table 2.

Table 2.

Clinical and sociodemographic characteristics of the study participants.

Subject ID Sex Age (T0) Severity level FSIQ Comorbidities Medications Length of hospital stay (days)
1 M 43.0 3 46 No No 104
2 M 21.1 3 66 No No 111
3 M 21.3 2 46 No No 119
4 M 21.9 2 43 No No 113
5 M 41.8 3 Not assessable Pica Trazodone; sodium valproate; risperidone; melatonin 110
6 M 20.2 2 46 No Risperidone; sodium valproate; clonazepam; clotiapine; quetiapine; chlorpromazine; hydroxyzine 114
7 M 22.0 3 <40 ADHD; developmental and epileptic encephalopathy of genetic etiology; Pica Sodium valproate; olanzapine; lorazepam; flurazepam 124
8 M 38.9 3 <40 No No 57
9 M 26.6 3 <40 Language disorder Aripiprazole; delorazepam; levomepromazine; trazodone; zolpidem 186
10 M 21.2 1 80 Borderline personality disorder No 108

ADHD, attention-deficit/hyperactivity disorder; FSIQ, Full-Scale Intelligence Quotient; T0, pre-admission assessment.

Descriptive statistics were calculated for all clinical measures at baseline (T0; pre-intervention) and discharge (T1; post-intervention). The number of valid observations varied across instruments, subscales, and assessment time points because of missing data. Descriptive statistics were therefore calculated separately for each measure using all available observations at the corresponding assessment time point. Table 3 summarizes the available sample size, mean, and standard deviation for the principal dimensions of the BPRS, ABC, CGI, and SSAF at T0 and T1. For the inferential analyses, each paired-samples t-test included only participants with valid scores at both assessment time points for the corresponding outcome. Accordingly, the findings should be interpreted cautiously given the small and variable number of complete pairs and the exploratory nature of the analyses.

Table 3.

Descriptive statistics for clinical and behavioral measures assessed at baseline (T0; pre-intervention) and discharge (T1; post-intervention).

Instrument Variable/subscale N (T0) M (T0) SD (T0) N (T1) M (T1) SD (T1)
BPRS Somatic concern 9 3.11 1.96 8 1.88 2.10
BPRS Anxiety 9 5.22 1.99 9 3.33 1.73
BPRS Motor tension 10 5.30 1.25 10 3.00 1.94
BPRS Distractibility 8 5.50 1.20 9 3.22 2.17
BPRS Bizarre behavior 9 5.67 1.73 10 3.10 2.13
BPRS Emotional withdrawal 10 4.90 1.85 10 3.00 1.05
BPRS Conceptual disorganization 8 4.63 1.69 9 3.44 1.67
ABC Irritability (ABC-I) 9 17.56 7.00 10 13.20 10.36
ABC Lethargy/Social withdrawal (ABC-II) 10 20.80 9.90 10 11.60 9.16
ABC Stereotypic behavior (ABC-III) 10 8.00 4.19 10 5.00 6.50
ABC Hyperactivity (ABC-IV) 10 20.90 10.17 10 11.40 10.78
ABC Inappropriate speech (ABC-V) 10 6.90 8.50 10 1.90 2.51
CGI Severity 8 6.00 0.53 10 5.20 0.79
SSAF Social support (no. of “yes” responses) 10 13.20 6.12 8 11.00 5.55

BPRS, Brief Psychiatric Rating Scale; ABC, Aberrant Behavior Checklist; CGI, Clinical Global Impression; SSAF, Social and Affective Functional Support Scale; M, mean; SD, standard deviation; T0, pre-intervention; T1, post-intervention.

Brief psychiatric rating scale

Descriptive statistics from the BPRS indicated that the highest mean baseline scores, relative to the other subscales, were observed for bizarre behavior (M = 5.67, SD = 1.73, N = 9), distractibility (M = 5.50, SD = 1.20, N = 8), motor tension (M = 5.30, SD = 1.25, N = 10), anxiety (M = 5.22, SD = 1.99, N = 9), self-neglect (M = 5.17, SD = 1.94, N = 6), mannerisms and posturing (M = 5.10, SD = 1.60, N = 10), and emotional withdrawal (M = 4.90, SD = 1.85, N = 10).

At discharge, mean scores were lower than at baseline across most BPRS domains. Anxiety decreased to M = 3.33 (SD = 1.73, N = 9), motor tension to M = 3.00 (SD = 1.94, N = 10), distractibility to M = 3.22 (SD = 2.17, N = 9), bizarre behavior to M = 3.10 (SD = 2.13, N = 10), emotional withdrawal to M = 3.00 (SD = 1.05, N = 10), and motor hyperactivity to M = 2.50 (SD = 1.78, N = 10). Reductions were also observed in unusual thought content, from M = 3.86 (SD = 2.27, N = 7) to M = 2.38 (SD = 2.00, N = 8), and conceptual disorganization, from M = 4.63 (SD = 1.69, N = 8) to M = 3.44 (SD = 1.67, N = 9).

Paired-samples t-test analyses of the BPRS subscales revealed statistically significant reductions in several symptom domains (Table 4). Significant improvements were observed for anxiety, t(7) = 3.15, p = .016, dz = 1.11, and somatic concern, t(6) = 2.59, p = .041, dz = 0.98. At the cognitive level, significant reductions were observed for unusual thought content, t(6) = 3.74, p = .010, dz = 1.41, and conceptual disorganization, t(6) = 4.21, p = .006, dz = 1.59 (Figure 1).

Table 4.

Results of paired-sample t-tests comparing T0 (pre-intervention) and T1 (post-intervention) scores on the Brief Psychiatric Rating (BPRS) subscales. .

Variable N (paired) t(df) p dz
Statistically significant findings
Somatic concern 7 2.59 (6) .041 0.98
Anxiety 8 3.15 (7) .016 1.11
Unusual thought content 7 3.74 (6) .010 1.41
Bizarre behavior 9 5.12 (8) <.001 1.71
Self-neglect 6 3.22 (5) .023 1.32
Conceptual disorganization 7 4.21 (6) .006 1.59
Emotional withdrawal 10 3.61 (9) .006 1.14
Motor tension 10 4.27 (9) .002 1.35
Distractibility 7 5.30 (6) .002 2.00
Motor hyperactivity 9 2.83 (8) .022 0.94
Non-significant findings
Mannerisms and posturing 10 2.24 (9) .052 0.71
Excitement 10 2.09 (9) .066 0.66
Suicide risk 4 2.32 (3) .103 1.16
Hallucinations 7 1.62 (6) .156 0.61
Non-cooperation 10 1.45 (9) .182 0.46
Guilt feelings 6 1.39 (5) .224 0.57
Suspiciousness 9 1.22 (8) .256 0.41
Elevated mood 9 1.11 (8) .301 0.37
Blunted affect 8 1.11 (7) .303 0.39
Depression 9 0.83 (8) .430 0.28
Disorientation 10 0.67 (9) .521 0.21
Hostility 10 −0.46 (9) .657 0.15
Grandiosity 9 −0.22 (8) .834 0.07
Motor retardation 10 0.13 (9) .899 0.04

df, degrees of freedom; dz, Cohen’s d for paired samples; N (paired), number of participants with valid scores at both T0 and T1. Each analysis included only participants with valid scores at both T0 and T1 for the corresponding subscale. Positive t values indicate lower scores at T1 than at T0; negative t values indicate higher scores at T1. Cohen’s dz is reported as an absolute magnitude. No correction for multiple comparisons was applied.

Figure 1.

Bar chart comparing mean scores of psychiatric symptoms pre-intervention (T0, blue bars) and post-discharge (T1, orange bars) across 20 dimensions. Most scores significantly decrease after intervention, indicated by asterisks denoting statistical significance.

Mean brief psychiatric rating (BPRS) subscale scores before (T0) and after (T1) the intervention. Asterisks denote uncorrected paired-samples t-tests (*p <.05; **p ≤.01; ***p <.001). disorg, disorganization; withd, withdrawal.

Behavioral dimensions also showed statistically significant reductions. These included bizarre behavior, t(8) = 5.12, p <.001, dz = 1.71, self-neglect, t(5) = 3.22, p = .023, dz = 1.32, distractibility, t(6) = 5.30, p = .002, dz = 2.00, and motor hyperactivity, t(8) = 2.83, p = .022, dz = 0.94. Significant reductions were also observed for motor tension, t(9) = 4.27, p = .002, dz = 1.35, and emotional withdrawal, t(9) = 3.61, p = .006, dz = 1.14.

No statistically significant differences were observed for depression, guilt, hostility, elevated mood, grandiosity, suspiciousness, hallucinations, disorientation, blunted affect, motor retardation, or non-cooperativeness (all p >.05). Mannerisms and posturing did not reach the statistical significance threshold, t(9) = 2.24, p = .052, dz = 0.71, although the effect size indicated a moderate-to-large within-subject reduction. Excitement also showed a non-significant reduction with a moderate effect size, t(9) = 2.09, p = .066, dz = 0.66. Suicide risk showed a large but non-significant reduction, t(3) = 2.32, p = .103, dz = 1.16; this estimate was based on only four complete pairs and should therefore be interpreted cautiously.

Aberrant behavior checklist

Descriptive statistics from the ABC indicated the following baseline mean scores: Irritability (ABC-I), M = 17.56 (SD = 7.00, N = 9); Lethargy/Social Withdrawal (ABC-II), M = 20.80 (SD = 9.90, N = 10); Stereotypic Behavior (ABC-III), M = 8.00 (SD = 4.19, N = 10); Hyperactivity/Noncompliance (ABC-IV), M = 20.90 (SD = 10.17, N = 10); and Inappropriate Speech (ABC-V), M = 6.90 (SD = 8.50, N = 10). Because the ABC subscales contain different numbers of items, their raw scores were not interpreted as directly comparable indicators of the relative severity of impairment across domains. At discharge, a reduction in the mean score was observed for every ABC subscale. Irritability/Agitation/Crying decreased to M = 13.20 (SD = 10.36, N = 10), Lethargy/Social Withdrawal to M = 11.60 (SD = 9.16, N = 10), and Hyperactivity/Noncompliance to M = 11.40 (SD = 10.78, N = 10). Stereotypic Behavior decreased to M = 5.00 (SD = 6.50, N = 10), while Inappropriate Speech decreased to M = 1.90 (SD = 2.51, N = 10).

Paired-samples t-test analyses revealed statistically significant reductions in Lethargy/Social Withdrawal (ABC-II), t(9) = 2.74, p = .023, dz = 0.87, and Hyperactivity/Noncompliance (ABC-IV), t(9) = 2.39, p = .041, dz = 0.76 (Figure 2). These findings indicated large within-subject reductions in social withdrawal and hyperactivity/noncompliance.

Figure 2.

Bar chart comparing mean scores for five ABC behavior domains at two timepoints: T0 (pre-intervention, blue bars) and T1 (post-discharge, orange bars). All domains show lower scores post-discharge, with significant reductions in Lethargy/SW (ABC-II) and Hyperactivity (ABC-IV), indicated by asterisks. Error bars represent plus or minus one standard error.

Mean aberrant behavior checklist (ABC) subscale scores before (T0) and after (T1) the intervention; error bars denote ±1 standard error (SE). Asterisks denote uncorrected paired-samples t-tests (*p <.05). ABC, Aberrant Behavior Checklist; ABC-I, Irritability; ABC-II, Lethargy/Social Withdrawal; ABC-III, Stereotypic Behavior; ABC-IV, Hyperactivity; ABC-V, Inappropriate Speech; SE, standard error; SW, social withdrawal.

The reduction in Irritability (ABC-I) was not statistically significant, t(8) = 1.10, p = .302, dz = 0.37. Similarly, no statistically significant differences were observed for Stereotypic Behavior (ABC-III), t(9) = 1.28, p = .234, dz = 0.40, or Inappropriate Speech (ABC-V), t(9) = 1.78, p = .109, dz = 0.56. The corresponding effect sizes indicated small-to-moderate reductions in Irritability/Agitation/Crying and Stereotypic Behavior and a moderate reduction in Inappropriate Speech.

Clinical global impression scale

Descriptive statistics from the Clinical Global Impression–Severity scale (CGI-S) indicated a baseline mean severity score of M = 6.00 (SD = 0.53, N = 8), corresponding approximately to a “severely ill” clinical rating. At discharge, the mean CGI-S score was M = 5.20 (SD = 0.79, N = 10). The Clinical Global Impression–Improvement scale (CGI-I), assessed exclusively at T1, showed a mean score of M = 2.56 (SD = 1.67, N = 9), corresponding on average to a clinical judgment between “much improved” and “minimally improved”.

The paired-samples analysis of CGI-S did not demonstrate a statistically significant reduction in overall clinical severity between T0 and T1, t(7) = 1.82, p = .111, dz = 0.64. Nevertheless, the descriptive reduction and corresponding effect size indicated a moderate within-subject change.

Perceived social support scale

For Part IV of the SSAF, which assesses social influences on behavior, the baseline mean number of affirmative responses was M = 13.20 (SD = 6.12, N = 10). At discharge, the mean was M = 11.00 (SD = 5.55, N = 8).

The paired-samples analysis did not reveal a statistically significant difference between T0 and T1, t(7) = 1.01, p = .348, dz = 0.36, indicating a small-to-moderate reduction in the number of affirmative responses.

Discussion

The present study aimed to evaluate the preliminary effectiveness of a clinical intervention delivered in the residential unit for severe behavioral disorders in autistic individuals, using a pre-post inpatient design and examining a broad spectrum of psychopathological, behavioral, and psychosocial functioning indicators. Rather than a uniform improvement, the findings indicated a differentiated pattern of change. Specifically, the post-intervention change was concentrated across a coherent set of behavioral-disorganization and agitation dimensions (i.e., motor tension, distractibility, bizarre behavior, conceptual disorganization, and anxiety), paralleled by reductions in emotional/social withdrawal and hyperactivity. By contrast, the more trait-like, affective, and global dimensions remained essentially unchanged.

The dimensions that improved are precisely those most plausibly operant in nature; that is, evoked and maintained by identifiable environmental contingencies and antecedents (14, 16); therefore, the ones most directly addressable by the methods used in the unit. Functional behavioral assessment identifies the variables that maintain a given challenging behavior, after which antecedent modification, extinction of the maintaining contingency, and differential reinforcement of an equally efficient, socially appropriate alternative can shift the behavioral repertoire away from the challenging topography (54–56). When that alternative is communicative, this is the logic of functional communication training, one of the most robust function-based treatments for severe behavior problems (57–59). Importantly, this rationale is also supported, although by a smaller literature, in autistic adults and in adults with intellectual and developmental disabilities (60, 61). On this account, the reductions in agitation, motor tension, and disorganized behavior are best read not as the direct “treatment” of discrete symptoms but as a reorganization of the behavioral repertoire toward functionally equivalent, better-regulated responses.

However, this interpretation must be held with caution, because a competing and non-exclusive explanation may operate in parallel. A highly structured, predictable, low-arousal inpatient environment removes or attenuates many of the antecedents and establishing operations that ordinarily evoke challenging behavior (62, 63). Part of the improvement observed at discharge may therefore reflect environmentally supported behavior under tight stimulus control rather than newly acquired, portable self-regulation (64). A single discharge assessment cannot distinguish durable, generalized learning from context-dependent suppression that may attenuate once the person returns to a less structured setting (65, 66). This is the classical problem of generalization and maintenance in behavior analysis (65, 67): gains do not transfer automatically and must be actively programmed across settings and caregivers (59, 66, 68). So framed, the post-discharge continuity built into the present model is not an administrative detail but a theoretically necessary condition for the observed gains to persist (63). This consideration extends beyond autism-specific behavior. Three of the dimensions showing significant change (i.e., motor tension, distractibility, and motor hyperactivity) together with the ABC Hyperactivity/Noncompliance subscale, describe motor restlessness, attentional dysregulation, and overactivity, and therefore overlap at the symptom level with the phenomenology of ADHD, which co-occurs in a substantial proportion of autistic individuals and is difficult to distinguish from autism-related presentations in adults with intellectual disability and limited spoken language (69, 70). Because the instruments employed here index the topography of observable behavior rather than its etiology, and because environmental structuring is itself a core component of the non-pharmacological management of attentional and hyperactive presentations, the admission may have acted in part on broader transdiagnostic dimensions of attentional, arousal, and behavioral dysregulation rather than exclusively on behavior specifically linked to autism. Two features of the present pattern, however, argue against comorbid ADHD as its principal explanation. First, the significant changes extended well beyond the dimensions with an ADHD counterpart, encompassing bizarre behavior, conceptual disorganization, unusual thought content, self-neglect, emotional withdrawal, and anxiety; these included the second, third, and fourth largest effect sizes observed. Second, a co-occurring diagnosis of ADHD was documented in only one of the ten participants. A comparable consideration applies to personality-related features: hostility and non-cooperation, the dimensions corresponding most closely to them, showed no significant change. At the same time, no ADHD-specific instrument was administered at T0 and T1, so change in attentional symptoms was not measured directly, and attentional and impulse-regulation difficulties in this population are liable to diagnostic overshadowing, so under-recognition cannot be excluded. Transdiagnostic dysregulation may therefore have contributed to, without fully accounting for, the improvement observed, a qualification that concerns what the change should be attributed to rather than whether it occurred. A further consideration concerns attribution. The admission is intrinsically multimodal, consistent with multidisciplinary approaches recommended for complex, challenging behaviors in neurodevelopmental disorders (71). Specifically, the behavioral program is delivered alongside systematic medical and pharmacological re-evaluation and a comprehensive environmental restructuring (71, 72). Acute behavioral deterioration in autistic adults is frequently precipitated or sustained by unrecognized somatic or psychiatric conditions, and addressing these is itself associated with clinical improvement (13, 73, 74). The present design cannot isolate the contribution of the behavioral component from these co-occurring elements. Therefore, the results are most accurately described as the effect of an integrated program, not of ABA in isolation.

Conversely, more stable or structural dimensions, such as depression, blunted affect, or grandiosity, did not show significant changes, suggesting lower short-term sensitivity to change. Several factors plausibly converge here. These dimensions may tap comparatively trait-like features and internalizing or psychotic-spectrum states that are less directly contingent on immediate environmental events and often show greater temporal complexity in the autistic population (75, 76). They are also more difficult to measure reliably in this population, where reduced introspective report and emotion-identification difficulties may affect the assessment of affective states (77–79), and where the risk of diagnostic overshadowing (i.e., the tendency to attribute affective or psychopathological signs to autism or intellectual disability itself) can blunt the detection of genuine change (80). This finding is consistent with the possibility that the behavioral components of the integrated program preferentially affected observable domains, in alignment with the wider ABA literature (14, 16, 19), whereas internalizing and affective symptoms, often characterized by greater stability and clinical complexity, may require different therapeutic approaches, such as adapted psychological interventions, pharmacological treatment of co-occurring psychiatric symptoms, or longer intervention periods to demonstrate significant improvement (81–83).

The ABC findings converge with those of the BPRS. Because the two instruments differ in source and item content yet point to the same selective signal, this convergence increases confidence that the effect is not an artifact of a single scale, while leaving the mechanistic account above unchanged. The reductions in social withdrawal and hyperactivity are consistent with the description of these manifestations as distinct topographies of a common underlying class of challenging behaviors (11). Although the Irritability subscale showed a moderate reduction, this change did not reach statistical significance. Inappropriate speech did not demonstrate significant changes, suggesting greater resistance to treatment in more structured communicative domains. A useful distinction could clarify this pattern. The communicative function of a challenging behavior may be directly targetable through functional communication training and has contributed to the behavioral reductions described above (59). By contrast, formal expressive language and pragmatic communication skills constitute a core and highly consolidated feature of autism in adulthood and change only slowly (5, 84, 85). Previous literature indicates that interventions targeting communication skills during the developmental age are associated with more favorable adult functional outcomes. Conversely, intervention on these abilities in adulthood may be more complex and require longer learning periods, as communicative patterns tend to be more consolidated and generalized across life contexts (5, 84, 86, 87). The absence of change in inappropriate speech is coherent with this view: a short admission can alter the function that maintains a behavior more readily than it can reshape entrenched communicative form.

Global assessment through the CGI did not reveal a statistically significant reduction in overall clinical severity, despite a trend toward improvement and a moderate effect size. This may be interpreted in light of the nature of the CGI, namely a broad, clinician-rated global impression scale that synthesizes overall illness severity or improvement into a small number of global ratings and is commonly used alongside more domain-specific symptom scales (88–90). As such, it may be less sensitive to circumscribed behavioral change than multi-item instruments targeting specific symptoms or behavioral domains. The severity of autism and the associated global functional impairment, primarily related to the autistic condition rather than to psychopathological or behavioral symptoms alone, are unlikely to change significantly within only a few months; longitudinal work indicates substantial continuity in autism-related features and support needs from childhood into adolescence and adulthood, even though specific behaviors and adaptive outcomes may vary across time (5, 84, 85, 91). The individual’s underlying autism severity and general support needs may thus remain stable while the challenging behaviors improve. At the same time, it should be noted that this comparison rested on a markedly small analyzable subsample, so the analysis was likely underpowered to detect an effect of this magnitude; therefore, the lack of statistical significance could reflect limited power at least as much as a genuine absence of clinical change. Similarly, no statistically significant changes emerged regarding perceived social support, assessed through the SSAF, consistent with the fact that perceived social support reflects a subjective appraisal of available relational support and would not necessarily be expected to shift over a brief inpatient admission unless the person’s social network or post-discharge support ecology also changes (92, 93). Also in this case, the paired analysis was based on only a limited number of observations, and this small subsample size further limits the power to detect possible change, independent of any substantive interpretation.

The temporary inpatient management of autistic individuals with challenging behaviors at IRCCS Maugeri, embedded within a coordinated regional territorial network, represents an innovative intervention model that, according to these preliminary clinical findings, appears to yield promising outcomes and supports the development of structured and specialized care pathways for these severe clinical conditions. Unlike other facilities currently operating at the national level, this model includes both upstream intervention through territorial healthcare teams and downstream intervention following discharge, involving gradual integration into post-discharge projects connected. This creates a coordinated “Piedmont Model” characterized by an integrated care pathway and an extensive outpatient territorial network coordinated by the two regional autism centers, interfacing directly with IRCSS Maugeri. As argued above, this upstream-downstream architecture is also the feature most likely to determine whether inpatient gains endure, since it provides the cross-setting continuity that the generalization of behavioral change requires.

Two years of operation have also yielded several practical observations about implementing such a model. During admission, staff members receive both external clinical supervision and internal psychological supervision focused on the emotional well-being of the multidisciplinary team, two fundamental elements in severe disability care settings, whose absence may contribute to maladaptive behavioral responses among healthcare workers. Before employment, staff members undergo a one-week “subjective trial” period, allowing them to assess their emotional suitability for this type of work, and the unit maintains a highly structured organization of staff responsibilities, which has progressively reduced staff turnover over time. The unit also collaborates with external organizations, promoting occupational activities within the facility’s garden areas. Throughout the pathway, an internal case manager for each patient (supported by a psychologist, behavior analyst, and psychiatrist) is considered essential, and the availability on site of other medical specialties (physiatry, cardiology, neurology), together with the nearby general hospital in Novara, allows direct evaluation of organic contributors to behavioral crises.

Overall, the findings delineate a coherent pattern: the intervention appears to be associated with improvement in the most dynamic and modifiable dimensions, whereas more global or structural dimensions appear less sensitive to short-term change. Nevertheless, they must be interpreted in light of several methodological limitations. First, the small sample size limits both generalizability and statistical power. Second, the absence of a control group precludes definitive causal attribution, as time-related or uncontrolled factors cannot be excluded. Third, the analyses were restricted to participants who completed the hospitalization program and underwent both baseline and discharge assessments. Consequently, the findings may not generalize to patients who discontinue the program. Some outcome-level data were also unavailable, resulting in variable numbers of complete T0-T1 pairs across measures and reducing the precision and statistical power of individual analyses. Fourth, a large number of subscale comparisons were performed without correction for multiple testing; consequently, some of the nominally significant results reported here may constitute false positives. Given this, the exploratory, hypothesis-generating nature of these analyses should be underscored, and interpretive weight should be placed on the overall consistency of the pattern of effect sizes across related dimensions and instruments, rather than on the statistical significance of any single comparison. Fifth, the exclusively male composition of the sample limits the generalizability of the findings to autistic women. This limitation is particularly relevant given evidence that females meeting criteria for ASD are less likely to receive a clinical diagnosis and may follow different diagnostic and referral pathways, partly because of differences in clinical presentation and camouflaging (94, 95). The present study cannot determine whether the absence of female participants reflects differences in the prevalence or severity of challenging behaviors, referral and admission practices, access to highly specialized services, or other contextual factors. Future multicenter studies should therefore actively examine the accessibility, clinical presentation, and treatment outcomes of autistic women with severe challenging behaviors. Sixth, feasibility and acceptability were not evaluated using standardized or prospectively defined measures. Similarly, the study did not include a dedicated systematic procedure for monitoring adverse events or unintended effects. Finally, and most importantly for interpretation, the absence of any assessment beyond discharge leaves the durability and cross-setting generalization of the gains untested, and the multimodal nature of the admission prevents isolation of the behavioral component from its medical and environmental co-interventions. Despite these limitations, the findings provide valuable preliminary evidence regarding the intervention, particularly in selected behavioral and disorganization-related domains. Future research should pre-specify a small set of primary outcomes, incorporate a control or comparison group and, where feasible, blinded outcome assessment, recruit larger and sex-diverse samples across multiple sites, and add post-discharge follow-up, along with adaptive functioning, quality of life, and caregiver burden measures. Prospective studies should also systematically document treatment completion, reasons for discontinuation, and any adverse or unintended effects. Such designs would allow the field to move from documenting that change occurs during admission to establishing whether it persists and generalizes afterwards, and to begin disentangling which components of the integrated program drive it.

Conclusions

This study provides preliminary, exploratory evidence that a specialized, time-limited inpatient program for severe challenging behaviors in autistic adults, delivered within an integrated three-tier regional network, is associated with measurable clinical improvement. Importantly, that improvement was selective rather than global; it concentrated in observable, operant dimensions of behavioral disorganization and agitation. Because the inpatient pathway combined behavioral intervention with medical and pharmacological re-evaluation and environmental restructuring, the observed changes are best understood as reflecting the integrated program as a whole, rather than the isolated effect of its ABA-based component. Moreover, as no post-discharge assessment was conducted, improvement refers exclusively to changes observed during hospitalization. Whether these gains persist over time, generalize to everyday settings, or depend on the highly structured inpatient environment remains to be established. Therefore, these findings should be read as hypothesis-generating. The uncontrolled design, the modest and exclusively male sample, and the absence of post-discharge measurement preclude causal claims and leave the durability and generalization of the gains untested. They nonetheless indicate that dedicated, coordinated care pathways are a promising direction for a markedly underserved population. The model’s distinctive upstream-downstream architecture, linking territorial services before admission with structured continuity after discharge, is precisely the feature most likely to determine whether inpatient gains endure.

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Antonio Narzisi, Stella Maris Foundation (IRCCS), Italy

Reviewed by: Guan-Jye Seng, National Taiwan University Hospital, Taiwan

Gergő Vida, University of West Hungary, Hungary

Emanuela Contardo, Azienda Provinciale per i Servizi Sanitari (APSS), Italy

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

This study was performed in line with the principles of the Declaration of Helsinki. This study was reviewed and approved by the COMITATO ETICO TERRITORIALE (CET) INTERAZIENDALE AOU CITTA’ DELLA SALUTE E DELLA SCIENZA DI TORINO, under approval/reference number 0000959. Personal privacy was protected when handling personal data, and we kept individual records completely secret. Informed consent was obtained from all individual participants included in the study. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

RK: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – original draft, Writing – review & editing. MG: Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing. FC: Data curation, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing, Formal analysis. MM: Data curation, Methodology, Writing – review & editing. SC: Data curation, Methodology, Writing – original draft, Writing – review & editing, Supervision. GF: Data curation, Methodology, Supervision, Writing – original draft, Writing – review & editing. MD: Data curation, Methodology, Writing – original draft, Writing – review & editing. DL: Formal analysis, Data curation, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author DL declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fift Edition, Text Revision (Dsm-V-Tr). (2022). doi:  10.1176/appi.books.9780890423349. [DOI] [Google Scholar]
  • 2. Hyman SL, Levy SE, Myers SM, Council on Children With Disabilities. Section on Developmental and Behavioral Pediatrics . Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. (2020) 145:e20193447. doi:  10.1542/peds.2019-3447 [DOI] [PubMed] [Google Scholar]
  • 3. Lai M-C, Anagnostou E, Wiznitzer M, Allison C, Baron-Cohen S. Evidence-based support for autistic people across the lifespan: maximising potential, minimising barriers, and optimising the person–environment fit. Lancet Neurol. (2020) 19:434–51. doi:  10.1016/S1474-4422(20)30034-X [DOI] [PubMed] [Google Scholar]
  • 4. Lord C, Charman T, Havdahl A, Carbone P, Anagnostou E, Boyd B, et al. The Lancet Commission on the future of care and clinical research in autism. Lancet. (2022) 399:271–334. doi:  10.1016/S0140-6736(21)01541-5 [DOI] [PubMed] [Google Scholar]
  • 5. Seltzer MM, Krauss MW, Shattuck PT, Orsmond G, Swe A, Lord C. The symptoms of autism spectrum disorders in adolescence and adulthood. J Autism Dev Disord. (2003) 33:565–81. doi:  10.1023/b:jadd.0000005995.02453.0b [DOI] [PubMed] [Google Scholar]
  • 6. Brighenti S, Schintu S, Liloia D, Keller R. Neuropsychological aspects of Asperger Syndrome in adults: a review. (2018). doi:  10.7358/neur-2018-024-brig [DOI] [Google Scholar]
  • 7. Adams D, Dargue N, Paynter J. Longitudinal studies of challenging behaviours in autistic children and adults: a systematic review and meta-analysis. Clin Psychol Rev. (2023) 104:102320. doi:  10.1016/j.cpr.2023.102320 [DOI] [PubMed] [Google Scholar]
  • 8. Newcomb ET, Hagopian LP. Treatment of severe problem behaviour in children with autism spectrum disorder and intellectual disabilities. Int Rev Psychiatry. (2018) 30:96–109. doi:  10.1080/09540261.2018.1435513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Steenfeldt-Kristensen C, Jones CA, Richards C. The prevalence of self-injurious behaviour in autism: a meta-analytic study. J Autism Dev Disord. (2020) 50:3857–73. doi:  10.1007/s10803-020-04443-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Emily G, Grace I. Family quality of life and ASD: the role of child adaptive functioning and behavior problems. Autism Res. (2015) 8:199–213. doi:  10.1002/aur.1442 [DOI] [PubMed] [Google Scholar]
  • 11. Rattaz C, Michelon C, Munir K, Baghdadli A. Challenging behaviours at early adulthood in autism spectrum disorders: topography, risk factors and evolution. J Intellectual Disability Res. (2018) 62:637–49. doi:  10.1111/jir.12503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Keller R, Chieregato S, Bari S, Castaldo R, Rutto F, Chiocchetti A, et al. Autism in adulthood: clinical and demographic characteristics of a cohort of five hundred persons with autism analyzed by a novel multistep network model. Brain Sci. (2020) 10:416. doi:  10.3390/brainsci10070416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Guinchat V, Cravero C, Diaz L, Périsse D, Xavier J, Amiet C, et al. Acute behavioral crises in psychiatric inpatients with autism spectrum disorder (ASD): recognition of concomitant medical or non-ASD psychiatric conditions predicts enhanced improvement. Res Dev Disabil. (2015) 38:242–55. doi:  10.1016/j.ridd.2014.12.020 [DOI] [PubMed] [Google Scholar]
  • 14. Beavers GA, Iwata BA, Lerman DC. Thirty years of research on the functional analysis of problem behavior. J Appl Behav Anal. (2013) 46:1–21. doi:  10.1002/jaba.30 [DOI] [PubMed] [Google Scholar]
  • 15. Hanley GP. Functional assessment of problem behavior: dispelling myths, overcoming implementation obstacles, and developing new lore. Behav Anal Pract. (2012) 5:54–72. doi:  10.1007/BF03391818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Hanley GP, Iwata BA, McCord BE. Functional analysis of problem behavior: a review. J Appl Behav Anal. (2003) 36:147–85. doi:  10.1901/jaba.2003.36-147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Horner RH, Carr EG, Strain PS, Todd AW, Reed HK. Problem behavior interventions for young children with autism: a research synthesis. J Autism Dev Disord. (2002) 32:423–46. doi:  10.1023/A:1020593922901 [DOI] [PubMed] [Google Scholar]
  • 18. Iwata BA, Dorsey MF, Slifer KJ, Bauman KE, Richman GS. Toward a functional analysis of self-injury. J Appl Behav Anal. (1994) 27:197–209. doi:  10.1901/jaba.1994.27-197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Baer DM, Wolf MM, Risley TR. Some current dimensions of applied behavior analysis. J Appl Behav Anal. (1968) 1:91–7. doi:  10.1901/jaba.1968.1-91 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Cooper JO, Heron T, Heward WL. Applied Behavior Analysis. Pearson UK; (2020). p. 2515. [Google Scholar]
  • 21. Eldevik S, Hastings RP, Hughes JC, Jahr E, Eikeseth S, Cross S. Meta-analysis of early intensive behavioral intervention for children with autism. J Clin Child Adolesc Psychol. (2009) 38:439–50. doi:  10.1080/15374410902851739 [DOI] [PubMed] [Google Scholar]
  • 22. Gitimoghaddam M, Chichkine N, McArthur L, Sangha SS, Symington V. Applied behavior analysis in children and youth with autism spectrum disorders: a scoping review. Perspect Behav Sci. (2022) 45:521–57. doi:  10.1007/s40614-022-00338-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Reichow B. Overview of meta-analyses on early intensive behavioral intervention for young children with autism spectrum disorders. J Autism Dev Disord. (2012) 42:512–20. doi:  10.1007/s10803-011-1218-9 [DOI] [PubMed] [Google Scholar]
  • 24. Reichow B, Hume K, Barton EE, Boyd BA. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev. (2018) 5:CD009260. doi:  10.1002/14651858.CD009260.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Virués-Ortega J. Applied behavior analytic intervention for autism in early childhood: meta-analysis, meta-regression and dose-response meta-analysis of multiple outcomes. Clin Psychol Rev. (2010) 30:387–99. doi:  10.1016/j.cpr.2010.01.008 [DOI] [PubMed] [Google Scholar]
  • 26. Bishop-Fitzpatrick L, Minshew NJ, Eack SM. A systematic review of psychosocial interventions for adults with autism spectrum disorders. J Autism Dev Disord. (2013) 43:687–94. doi:  10.1007/s10803-012-1615-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Baiden KMP, Williams ZJ, Schuck RK, Dwyer P, Wang M. The social validity of behavioral interventions: seeking input from autistic adults. J Autism Dev Disord. (2025) 55:1172–86. doi:  10.1007/s10803-024-06297-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Benevides TW, Shore SM, Palmer K, Duncan P, Plank A, Andresen M-L, et al. Listening to the autistic voice: mental health priorities to guide research and practice in autism from a stakeholder-driven project. Autism. (2020) 24:822–33. doi:  10.1177/1362361320908410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Bottema-Beutel K, Crowley S, Sandbank M, Woynaroski TG. Research review: conflicts of interest (COIs) in autism early intervention research - a meta-analysis of COI influences on intervention effects. J Child Psychol Psychiatry. (2021) 62:5–15. doi:  10.1111/jcpp.13249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Wilkenfeld DA, McCarthy AM. Ethical concerns with applied behavior analysis for autism spectrum “disorder. Kennedy Inst Ethics J. (2020) 30:31–69. doi:  10.1353/ken.2020.0000 [DOI] [PubMed] [Google Scholar]
  • 31. Maloret P, Scott T. Don’t ask me what’s the matter, ask me what matters: acute mental health facility experiences of people living with autism spectrum conditions. J Psychiatr Ment Health Nurs. (2018) 25:49–59. doi:  10.1111/jpm.12438 [DOI] [PubMed] [Google Scholar]
  • 32. Williams G, Corbyn J, Hart A. Improving the sensory environments of mental health in-patient facilities for autistic children and young people. Child Care Pract. (2023) 29:35–53. doi:  10.1080/13575279.2022.2126437 37339054 [DOI] [Google Scholar]
  • 33. Taylor BJ, Sanders KB, Kyle M, Pedersen KA, Veenstra-Vanderweele J, Siegel M. Inpatient psychiatric treatment of serious behavioral problems in children with autism spectrum disorder (ASD): specialized versus general inpatient units. J Autism Dev Disord. (2019) 49:1242–9. doi:  10.1007/s10803-018-3816-2 [DOI] [PubMed] [Google Scholar]
  • 34. Hagopian LP, Kurtz PF, Bowman LG, O’Connor JT, Cataldo MF. A neurobehavioral continuum of care for individuals with intellectual and developmental disabilities with severe problem behavior. Child Health Care. (2023) 52:45–69. doi:  10.1080/02739615.2021.1987237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Melvin CL, Barnoux M, Alexander R, Roy A, Devapriam J, Blair R, et al. A systematic review of in-patient psychiatric care for people with intellectual disabilities and/or autism: effectiveness, patient safety and experience. BJPsych Open. (2022) 8:e187. doi:  10.1192/bjo.2022.571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Bloemert H, Sizoo BB, Verhoeven EWM, Beekman A, van Meijel B. Recovery of adults with autism spectrum disorder during intensive inpatient treatment: a qualitative study. Front Psychiatry. (2024) 15. doi:  10.3389/fpsyt.2024.1383138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Hassiotis A, Walsh A, Budgett J, Harrison I, Jones R, Morant N, et al. Intensive support for adults with intellectual disability and behaviours that challenge: a survey of provision and service typologies in England. BJPsych Open. (2020) 6:e20. doi:  10.1192/bjo.2020.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Kouroupa A, Hassiotis A, Hamza L, Courtenay K, Hall I, Langdon PE, et al. Stakeholder perspectives on intensive support teams for adults with intellectual disabilities who display behaviour that challenges in England. J Appl Res Intellect Disabil. (2023) 36:1101–12. doi:  10.1111/jar.13129 [DOI] [PubMed] [Google Scholar]
  • 39. McNellis CA, Harris T. Residential treatment of serious behavioral disturbance in autism spectrum disorder and intellectual disability. Child Adolesc Psychiatr Clin N Am. (2014) 23:111–24. doi:  10.1016/j.chc.2013.08.005 [DOI] [PubMed] [Google Scholar]
  • 40. Pedersen KA, Santangelo SL, Gabriels RL, Righi G, Erard M, Siegel M. Behavioral outcomes of specialized psychiatric hospitalization in the Autism Inpatient Collection (AIC): a multisite comparison. J Autism Dev Disord. (2018) 48:3658–67. doi:  10.1007/s10803-017-3366-z [DOI] [PubMed] [Google Scholar]
  • 41. Siegel M, Milligan B, Chemelski B, Payne D, Ellsworth B, Harmon J, et al. Specialized inpatient psychiatry for serious behavioral disturbance in autism and intellectual disability. J Autism Dev Disord. (2014) 44:3026–32. doi:  10.1007/s10803-014-2157-z [DOI] [PubMed] [Google Scholar]
  • 42. Fulceri F, Gila L, Caruso A, Micai M, Romano G, Scattoni ML. Building bricks of integrated care pathway for autism spectrum disorder: a systematic review. Int J Mol Sci. (2023) 24:6222. doi:  10.3390/ijms24076222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Valenti M, Mazza M, Arduino GM, Keller R, Le Donne I, Masedu F, et al. Diagnostic assessment, therapeutic care and education pathways in persons with autism spectrum disorder in transition from childhood to adulthood: the Italian National Ev.A Longitudinal Project. Ann Ist Super Sanita. (2023) 59:304–12. doi:  10.4415/ANN_23_04_10 [DOI] [PubMed] [Google Scholar]
  • 44. Keller R, Capiotto F, Nobile E, Ferreri A, Brighenti S, Bartolo ED, et al. Implementing a multistep network model for adult autism care: evidence from the Piedmont Region. Curr Soc Sci. (2025) 3:219–28. doi:  10.2174/012772316X420189251128065533 [DOI] [Google Scholar]
  • 45. Wechsler D. Wechsler Adult Intelligence Scale—Fourth Edition (Wais-Iv). San Antonio, TX: Pearson; (2008). [Google Scholar]
  • 46. Lord C, Rutter M, DiLavore PC, Risi S, Gotham K, Bishop SL. Autism Diagnostic Observation Schedule, Second Edition (Ados-2). Torrance, CA: Western Psychological Services; (2012). [Google Scholar]
  • 47. Rutter M, Le Couteur A, Lord C. Autism Diagnostic Interview–Revised (Adi-R). Los Angeles, CA: Western Psychological Services; (2003). [Google Scholar]
  • 48. Kooij JJS, Francken MH, Bron TI. Diagnostic Interview for ADHD in Adults, Fifth Edition (Diva-5). The Hague: DIVA Foundation; (2019). [Google Scholar]
  • 49. First MB, Williams JBW, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5 Disorders, Clinician Version (Scid-5-Cv). Arlington, VA: American Psychiatric Association Publishing; (2016). [Google Scholar]
  • 50. Ventura J, Lukoff D, Nuechterlein K, Liberman R, Green M, Shaner A, et al. Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0): Scales, Anchor Points, and Administration Manual (1993). Available online at: https://www.semanticscholar.org/paper/Brief-Psychiatric-Rating-Scale-(BPRS)-Expanded-and-Ventura-Lukoff/5a44c4a26d84880d3ae863a0854b9da4df1c3df9 (Accessed June 11, 2026).
  • 51. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. (1985) 89:485–91. [PubMed] [Google Scholar]
  • 52. Guy W. Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology, revised (1976). Available online at: https://www.scirp.org/reference/ReferencesPapers?ReferenceID=1153932 (Accessed June 01, 2026).
  • 53. Iwata BA, Deleon IG, Roscoe EM. Reliability and validity of the functional analysis screening tool. J Appl Behav Anal. (2013) 46:271–84. doi:  10.1002/jaba.31 [DOI] [PubMed] [Google Scholar]
  • 54. Athens ES, Vollmer TR. An investigation of differential reinforcement of alternative 604 behavior without extinction. J Appl Behav Anal. (2010) 43:569–89. doi:  10.1901/jaba.2010.43-569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Hagopian LP, Fisher WW, Sullivan MT, Acquisto J, LeBlanc LA. Effectiveness of functional communication training with and without extinction and punishment: a summary of 21 inpatient cases. J Appl Behav Anal. (1998) 31:211–35. doi:  10.1901/jaba.1998.31-211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Horner RH, Day HM. The effects of response efficiency on functionally equivalent competing behaviors. J Appl Behav Anal. (1991) 24:719–32. doi:  10.1901/jaba.1991.24-719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Carr EG, Durand VM. Reducing behavior problems through functional communication training. J Appl Behav Anal. (1985) 18:111–26. doi:  10.1901/jaba.1985.18-111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Gerow S, Davis T, Radhakrishnan S, Gregori E, Rivera G. Functional communication training: the strength of evidence across disabilities. Exceptional Children. (2018) 85:86–103. doi:  10.1177/0014402918793399 [DOI] [Google Scholar]
  • 59. Tiger JH, Hanley GP, Bruzek J. Functional communication training: a review and practical guide. Behav Anal Pract. (2008) 1:16–23. doi:  10.1007/BF03391716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Gregori E, Wendt O, Gerow S, Peltier C, Genc-Tosun D, Lory C, et al. Functional communication training for adults with autism spectrum disorder: a systematic review and quality appraisal. J Behav Educ. (2020) 29:42–63. doi:  10.1007/s10864-019-09339-4 30311153 [DOI] [Google Scholar]
  • 61. Muharib R, Gregori E. A systematic and quality review of function-based interventions for adults with intellectual and developmental disabilities. J Dev Phys Disabil. (2022) 34:739–73. doi:  10.1007/s10882-021-09825-6 30311153 [DOI] [Google Scholar]
  • 62. McGill P. Establishing operations: implications for the assessment, treatment, and prevention of problem behavior. J Appl Behav Anal. (1999) 32:393–418. doi:  10.1901/jaba.1999.32-393 [DOI] [Google Scholar]
  • 63. Smith RG, Iwata BA. Antecedent influences on behavior disorders. J Appl Behav Anal. (1997) 30:343–75. doi:  10.1901/jaba.1997.30-343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Kirby KC, Bickel WK. Toward an explicit analysis of generalization: a stimulus control interpretation. Behav Analyst. (1988) 11:115–29. doi:  10.1007/BF03392465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Stokes TF, Baer DM. An implicit technology of generalization. J Appl Behav Anal. (1977) 10:349–67. doi:  10.1901/jaba.1977.10-349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Swan AJ, Carper MM, Kendall PC. In pursuit of generalization: an updated review. Behav Ther. (2016) 47:733–46. doi:  10.1016/j.beth.2015.11.006 [DOI] [PubMed] [Google Scholar]
  • 67. Stokes TF, Osnes PG. An operant pursuit of generalization. Behav Ther. (1989) 20:337–55. doi:  10.1016/S0005-7894(89)80054-1 [DOI] [PubMed] [Google Scholar]
  • 68. Durand VM, Carr EG. Functional communication training to reduce challenging behavior: maintenance and application in new settings. J Appl Behav Anal. (1991) 24:251–64. doi:  10.1901/jaba.1991.24-251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Rong Y, Yang C-J, Jin Y, Wang Y. Prevalence of attention-deficit/hyperactivity disorder in individuals with autism spectrum disorder: a meta-analysis. Res Autism Spectr Disord. (2021) 83:101759. doi:  10.1016/j.rasd.2021.101759 38826717 [DOI] [Google Scholar]
  • 70. Antshel KM, Russo N. Autism spectrum disorders and ADHD: overlapping phenomenology, diagnostic issues, and treatment considerations. Curr Psychiatry Rep. (2019) 21:34. doi:  10.1007/s11920-019-1020-5 [DOI] [PubMed] [Google Scholar]
  • 71. Guinchat V, Cravero C, Lefèvre-Utile J, Cohen D. Chapter 22 - Multidisciplinary treatment plan for challenging behaviors in neurodevelopmental disorders. In: Gallagher A, Bulteau C, Cohen D, Michaud JL, editors. Neurocognitive Development: Disorders and Disabilities. Elsevier; (2020). p. 301–21. doi:  10.1016/B978-0-444-64148-9.00022-3 [DOI] [PubMed] [Google Scholar]
  • 72. Sawyer A, Lake JK, Lunsky Y, Liu S-K, Desarkar P. Psychopharmacological treatment of challenging behaviours in adults with autism and intellectual disabilities: a systematic review. Res Autism Spectr Disord. (2014) 8:803–13. doi:  10.1016/j.rasd.2014.03.021 38826717 [DOI] [Google Scholar]
  • 73. Lugo-Marín J, Magán-Maganto M, Rivero-Santana A, Cuellar-Pompa L, Alviani M, Jenaro-Rio C, et al. Prevalence of psychiatric disorders in adults with autism spectrum disorder: a systematic review and meta-analysis. Res Autism Spectr Disord. (2019) 59:22–33. doi:  10.1016/j.rasd.2018.12.004 38826717 [DOI] [Google Scholar]
  • 74. Tye C, Runicles AK, Whitehouse AJO, Alvares GA. Characterizing the interplay between autism spectrum disorder and comorbid medical conditions: an integrative review. Front Psychiatry. (2019) 9. doi:  10.3389/fpsyt.2018.00751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS. Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med. (2019) 49:559–72. doi:  10.1017/S0033291718002283 [DOI] [PubMed] [Google Scholar]
  • 76. Schiltz H, Sterrett K, Singer H, Lord C. Anxiety, depression, and well-being in autistic adults and adults with other developmental disabilities: a longitudinal cross-lagged analysis. Autism Res. (2023) 16:1425–36. doi:  10.1002/aur.2967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Cassidy SA, Bradley L, Bowen E, Wigham S, Rodgers J. Measurement properties of tools used to assess depression in adults with and without autism spectrum conditions: a systematic review. Autism Res. (2018) 11:738–54. doi:  10.1002/aur.1922 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Kinnaird E, Stewart C, Tchanturia K. Investigating alexithymia in autism: a systematic review and meta-analysis. Eur Psychiatry. (2019) 55:80–9. doi:  10.1016/j.eurpsy.2018.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Williams ZJ, Gotham KO. Improving the measurement of alexithymia in autistic adults: a psychometric investigation of the 20-item Toronto Alexithymia Scale and generation of a general alexithymia factor score using item response theory. Mol Autism. (2021) 12:56. doi:  10.1186/s13229-021-00463-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Reiss S, Levitan GW, Szyszko J. Emotional disturbance and mental retardation: diagnostic overshadowing. Am J Ment Defic. (1982) 86:567–74. [PubMed] [Google Scholar]
  • 81. Linden A, Best L, Elise F, Roberts D, Branagan A, Tay YBE, et al. Benefits and harms of interventions to improve anxiety, depression, and other mental health outcomes for autistic people: a systematic review and network meta-analysis of randomised controlled trials. Autism. (2023) 27:7–30. doi:  10.1177/13623613221117931 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Manter MA, Birtwell KB, Bath J, Friedman NDB, Keary CJ, Neumeyer AM, et al. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Med. (2025) 23:11. doi:  10.1186/s12916-024-03814-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Spain D, Sin J, Chalder T, Murphy D, Happé F. Cognitive behaviour therapy for adults with autism spectrum disorders and psychiatric co-morbidity: a review. Res Autism Spectr Disord. (2015) 9:151–62. doi:  10.1016/j.rasd.2014.10.019 38826717 [DOI] [Google Scholar]
  • 84. Howlin P, Moss P. Adults with autism spectrum disorders. Can J Psychiatry. (2012) 57:275–83. doi:  10.1177/070674371205700502 [DOI] [PubMed] [Google Scholar]
  • 85. Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, et al. Autism spectrum disorder. Nat Rev Dis Primers. (2020) 6:5. doi:  10.1038/s41572-019-0138-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Howlin P, Moss P, Savage S, Rutter M. Social outcomes in mid- to later adulthood among individuals diagnosed with autism and average nonverbal IQ as children. J Am Acad Child Adolesc Psychiatry. (2013) 52:572–81:e1. doi:  10.1016/j.jaac.2013.02.017 [DOI] [PubMed] [Google Scholar]
  • 87. LeGrand KJ, Weil LW, Lord C, Luyster RJ. Identifying childhood expressive language features that best predict adult language and communication outcome in individuals with autism spectrum disorder. J Speech Language Hearing Res. (2021) 64:1977–91. doi:  10.1044/2021_JSLHR-20-00544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Busner J, Targum SD. The clinical global impressions scale. Psychiatry (Edgmont). (2007) 4:28–37. doi:  10.1016/j.comppsych.2008.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Dunlop BW, Gray J, Rapaport MH. Transdiagnostic Clinical Global Impression scoring for routine clinical settings. Behav Sci. (2017) 7:1–10. doi:  10.3390/bs7030040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Kolevzon A, Ventola P, Keary CJ, Heimer G, Neul JL, Adera M, et al. Development of an adapted Clinical Global Impression scale for use in Angelman syndrome. J Neurodevelop Disord. (2021) 13:3. doi:  10.1186/s11689-020-09349-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Elias R, Lord C. Diagnostic stability in individuals with autism spectrum disorder: insights from a longitudinal follow-up study. J Child Psychol Psychiatry. (2022) 63:973–83. doi:  10.1111/jcpp.13551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Alvarez-Fernandez S, Brown HR, Zhao Y, Raithel JA, Bishop SL, Kern SB, et al. Perceived social support in adults with autism spectrum disorder and attention-deficit/hyperactivity disorder. Autism Res. (2017) 10:866–77. doi:  10.1002/aur.1735 [DOI] [PubMed] [Google Scholar]
  • 93. van den Heuvel RM, Wensing M, Geurts HM, Teunisse J-P. The social support network of adults with an autism spectrum condition: an exploration using the Network in Action-Questionnaire. J Autism Dev Disord. (2023) 53:1974–88. doi:  10.1007/s10803-022-05467-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Loomes R, Hull L, Mandy WPL. What is the male-to-female ratio in autism spectrum disorder? a systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. (2017) 56:466–74. doi:  10.1016/j.jaac.2017.03.013 [DOI] [PubMed] [Google Scholar]
  • 95. Hull L, Lai M-C, Baron-Cohen S, Allison C, Smith P, Petrides KV, et al. Gender differences in self-reported camouflaging in autistic and non-autistic adults. Autism. (2020) 24:352–63. doi:  10.1177/1362361319864804 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Psychiatry are provided here courtesy of Frontiers Media SA

RESOURCES